VOTING AGREEMENTVoting Agreement • December 14th, 2017 • KalVista Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
This Voting Agreement (this “Agreement”) is made and entered into as of October 6, 2017 by and among KalVista Pharmaceuticals, Inc., a Delaware corporation (the “Company”), Merck Sharp & Dohme Corp., a New Jersey Corporation (the “Investor” and, together with the Company, the “Parties”). Capitalized terms contained and not otherwise defined herein shall have the meaning ascribed to such terms in the Purchase Agreement (defined below).
OPTION AGREEMENTOption Agreement • December 14th, 2017 • KalVista Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
This Asset Purchase and License Agreement (this “Agreement”) is entered into as of [●] (the “Agreement Date”), by and between [Merck], a [●] (“Merck”), and KalVista Pharmaceuticals Limited, a private company limited by shares incorporated and registered in England and Wales (“KalVista”). Merck and KalVista may each be referred to herein as a “Party” and collectively as the “Parties”.
STOCK PURCHASE AGREEMENT dated as of October 6, 2017 between KALVISTA PHARMACEUTICALS, INC., andStock Purchase Agreement • December 14th, 2017 • KalVista Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
This STOCK PURCHASE AGREEMENT (“Agreement”) is made and entered into as of October 6, 2017, by and between KalVista Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Merck Sharp & Dohm Corp., a New Jersey corporation (“Investor” and together with the Company, the “Parties”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • December 14th, 2017 • KalVista Pharmaceuticals, Inc. • Pharmaceutical preparations • Massachusetts
This Executive Employment Agreement (“Agreement”) is made and entered into on this 21st day of August, 2017 by and between KalVista Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Andreas Maetzel (hereinafter, the “Executive”).
